You are here: Home » News-CM » Equities » Hot Pursuit
Business Standard

Laurus Labs firms up after partnership with Global Fund

Capital Market 

rose 3.38% to Rs 387.15 at 14:17 IST on BSE after the company said it entered into strategic partnership agreement with the

The announcement was made during trading hours today, 26 March 2019.

Meanwhile, the S&P was up 194.27 points, or 0.51% to 38,003.18.

On the BSE, 11,000 shares were traded in the counter so far compared with average daily volumes of 9.12 lakh shares in the past two weeks. The stock had hit a high of Rs 390.25 and a low of Rs 374 so far during the day. The stock hit a 52-week high of Rs 520 on 3 April 2018. The stock hit a 52-week low of Rs 324 on 18 February 2019.

said it has entered into a strategic partnership agreement with for a period of 3.5 years. Through this long term agreement will have the volume commitments from the for the treatment of HIV/AIDS.

Under this partnership agreement Laurus Labs received and executed the order from Global Fund which would cater to the supplies of the high burden diseases countries in Sub Saharan African (SSA) region. This is the maiden order for Tenofovir/Lamivudine/300/300/50mg (TLD) after the company received a tentative approval from (USFDA) in the month of February 2019.

Laurus Labs believes that this strategic partnership with Global Fund would increase the access for the HIV/by meeting the unmet needs, helping to save the lives of millions.

The Global Fund is a 21st-century partnership organization designed to accelerate the end of AIDS, as epidemics.

On a consolidated basis, net profit of Laurus Labs declined 48.90% to Rs 17.82 crore on 10.55% rise in net sales to Rs 529.46 crore in Q3 December 2018 over Q3 December 2017.

Laurus Labs is a leading research & development driven and fully integrated company in

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, March 26 2019. 14:18 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU